Want Better Skin? Using This 1 Thing Before Bed Can Help And It’s Already In Your Home
HuffPost’s “Am I Doing It Wrong” chatted with Dr. Sherwin Parikh to get the lowdown on a nighttime skincare routine that will get you glowing.
Similar Posts
Covid Inquiry: Abuse of experts must stop, says Whitty
Sir Chris laments treatment as he gives evidence to Covid Inquiry on pandemic preparedness.
At-home health test maker Thorne explores sale | Reuters News Agency
Business & FinanceDealsHealth 21 July 2023, 6:41 pm 1 minute Reuters exclusively reported that Thorne HealthTech Inc (THRN.O), a provider of at-home health tests and nutritional supplements, is exploring a sale. Market Impact Thorne’s shares ended trading on Friday up 12.9% at $5.95 on the news, giving the company a market value of $320 million….
J&J to acquire cancer drug developer Ambrx Biopharma for $2 billion
An entry sign to the Johnson & Johnson campus shows their logo in Irvine, California on August 28, 2019. Mark Ralston | AFP | Getty Images Johnson & Johnson on Monday said it will pay $2 billion in cash to acquire Ambrx Biopharma, a drugmaker specializing in one of the hottest areas of cancer treatment….
Jamie Foxx Is Recovering After Being Hospitalized For A “Medical Complication”
Jamie Foxx is currently recovering from an unspecified medical emergency that reportedly hospitalized him. On Wednesday, Corinne Foxx, the daughter of the Oscar-winning actor, posted a statement to Instagram on behalf of the Foxx family that said he had “experienced a medical complication” the day prior. “Luckily, due to quick action and great care, he…
Uptick in respiratory illnesses across the U.S.
Uptick in respiratory illnesses across the U.S. – CBS News Watch CBS News Several states are reporting high levels of influenza this holiday season. While nationwide, less than half of children and adults have gotten the flu vaccine. Lilia Luciano has more. Be the first to know Get browser notifications for breaking news, live events,…
Cystic fibrosis: The miracle drugs priced out of reach
Regulators around the world have questioned the high price set by Vertex Pharmaceuticals.
